Psychoemothional factors and 24-hour blood pressure profile in men with hypertension

   Objective: to perform comprehensive analysis of serum cortisol levels and 24-hour blood pressure profile in male patients with arterial hypertension with or without obesity, and to investigate relationship of blood pressure profile with psychological stress and anxiety levels.

   Materials and methods: the study included 76 hypertensive male patients (mean age 46.7 ± 0.5 years). Group 1 included 36 hypertensive men with obesity, group 2 — 40 hypertensive men without obesity. Сontrol group included 26 practically healthy men, comparable in age with groups 1 and 2 (mean age 42.58 ± 1.45 years). All patients underwent 24-hour blood pressure monitoring. Serum cortisol levels was assessed by enzyme immunoassay using Cortisol-IFA-BEST reagent kit. The level of psychological stress was determined by PSM-25 scale. The level of reactive and personal anxiety was determined by Spielberger-Khanin questionnaire.

   Results: there was a significant increase in average 24-hour, daytime and nighttime blood pressure values, its variability and decline in the nocturnal blood pressure fall (p < 0.05). The highest level of cortisol — 890.2 ± 56.7 nmol / l was detected in group 1 (p < 0.05 compared to group 2 and control group). Correlation analysis revealed significant relationships of blood pressure variability and nocturnal blood pressure fall with the level of anxiety and psychological stress, as well as with cortisol blood levels.

   Conclusion: the presence of increased anxiety and psychological stress in patients with hypertension is associated with decline in the nocturnal blood pressure fall and increase in its 24-hour variability, to a greater extent when hypertension is accompanied by obesity.

1. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398(10304):957-980. Erratum in: Lancet. 2022;399(10324):520. DOI: 10.1016/S0140-6736(21)01330-1. Epub 2021 Aug 24.

2. Kobalava Zh.D., Konradi A.O., Nedogoda S.V., Shlyakhto E.V., Arutyunov G.P., Baranova E.I., et al. 2024 Clinical practice guidelines for Hypertension in adults. Russian Journal of Cardiology. 2024;29(9):6117. (In Russ.) DOI: 10.15829/1560-4071-2024-6117

3. Rotar O.P., Ilyanova I.N., Boyarinova M.A., Moguchaya E.V., Tolkunova K.M., Dyachkov V.A., et al. 2023 All-Russian screening for hypertension: results. Russian Journal of Cardiology. 2024;29(5):5931. (In Russ.) DOI: 10.15829/1560-4071-2024-5931

4. Balanova Yu.A., Shalnova S.A., Kutsenko V.A., Imaeva A.E., Kapustina A.V., Muromtseva G.A., et al. Contribution of hypertension and other risk factors to survival and mortality in the Russian population. Cardiovascular Therapy and Prevention. 2021;20(5):3003. (In Russ.) DOI: 10.15829/1728-8800-2021-3003

5. Pogosova N.V., Boytsov S.A., Oganov R.G., Yufereva Yu.M., Kostyuk G.P., Kursakov A.A., et al. Clinical-Epidemiological Program of Studying Psychosocial Risk Factors in Cardiological Practice in Patients With Arterial Hypertension and Ischemic Heart Disease: First Results of a Multicenter Study in Russia. Kardiologiia. 2018;58(9):47-58. (In Russ.) DOI: 10.18087/cardio.2018.9.10171

6. Pchelenok J.V., Fomicheva A.V., Kanaeva M., Rodionov A.V., Tolokonin A.O., Volel B.A. The influence of anxiety and depressive disorders on the development of resistant arterial hypertension. Systemic Hypertension. 2024;21(2):51-57. (In Russ.) DOI: 10.38109/2075-082X-2024-2-49-55

7. Drapkina O.M., Fedin A.I., Dorofeeva O.A., Medvedev V.E., Kareva E.N., Dzhioeva O.N., et al. Influence of psychosocial risk factors on the course and prognosis of cardiovascular diseases. Cardiovascular Therapy and Prevention. 2022;21(5):3280. (In Russ.) DOI: 10.15829/1728-8800-2022-3280

8. Sorokin M.Yu., Kasyanov E.D., Rukavishnikov G.V., Makarevich O.V., Neznanov N.G., Lutova N.B., et al. Psychological reactions of the population as a factor of adaptation to the COVID-19 pandemic. V.M. Bekhterev review of psychiatry and medical psychology. 2020;(2):87-94. (In Russ.) DOI: 10.31363/2313-7053-2020-2-87-94

9. Agarkov N.M., Okhotnikov O.I., Korneeva S.I., Moskaleva E.O., Moskalev A.A., Kolomiec V.I., et al. Psychological continuum of elderly hypertensive patients with metabolic syndrome receiving chronotherapy with a fixed-dose combination of amlodipine, lisinopril and rosuvastatin. Russian Journal of Cardiology. 2021;26(2):4312. (In Russ.) DOI: 10.15829/1560-4071-2021-4312

10. Stergiou GS, Palatini P, Parati G, O’Brien E, Januszewicz A, Lurbe E, et al. 2021 European Society of Hypertension practice guidelines for office and out-of-office blood pressure measurement. J Hypertens. 2021;39(7):1293-1302. DOI: 10.1097/HJH.0000000000002843

11. Tadic M, Cuspidi C, Grassi G, Mancia G. Isolated Nocturnal Hypertension: What Do We Know and What Can We Do? Integr Blood Press Control. 2020;13:63-69. DOI: 10.2147/IBPC.S223336

12. Strigaleva K.A., Gromova E.A., Gagulin I.V., Panov D.O., Gafarova A.V., Gafarov V.V. Gendernye razlichiya v riske razvitiya arterial’noi gipertenzii sredi lits 25–64 let s vysokim urovnem lichnostnoi trevozhnosti (programma VOZ «MONICA-psikhosotsial’naya»). Ateroskleroz. 2023;19(3):241-243. (In Russ.) DOI: 10.52727/2078-256X-2023-19-3-241-243

13. Małyszczak K, Janocha A. The circadian rhythm of blood pressure in patients with panic disorder and generalized anxiety disorder. J Psychosom Res. 2022;161:110999. DOI: 10.1016/j.jpsychores.2022.110999

14. Casagrande M, Favieri F, Langher V, Guarino A, Di Pace E, Germanò G, et al. The Night Side of Blood Pressure: Nocturnal Blood Pressure Dipping and Emotional (dys)Regulation. Int J Environ Res Public Health. 2020;17(23):8892. DOI: 10.3390/ijerph17238892

15. Shahimi NH, Lim R, Mat S, Goh CH, Tan MP, Lim E. Association between mental illness and blood pressure variability : a systematic review. Biomed Eng Online. 2022;21(1):19. DOI: 10.1186/s12938-022-00985-w

16. Lee SY, Lee JP, Lee J, Park JY, Kim EY. Association between depressive symptoms and the risk of all-cause and cardiovascular mortality among US adults. Prog Neuropsychopharmacol Biol Psychiatry. 2023;125:110755. DOI: 10.1016/j.pnpbp.2023.110755